世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

グリコサミノコンドロイチンサプリメントの世界市場成長 2023-2029


Global Glycosaminochondroitin Supplements Market Growth 2023-2029

LPI(エルピーアイ情報)の最新調査によると、グリコサミノコンドロイチンサプリメントの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加に伴い、グリコサミノコンドロイチンサプリ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年10月30日 US$3,660
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(エルピーアイ情報)の最新調査によると、グリコサミノコンドロイチンサプリメントの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加に伴い、グリコサミノコンドロイチンサプリメントは、レビュー期間中の年平均成長率(CAGR)%で2029年までに百万米ドルの再調整規模になると予測されています。
この調査レポートは、世界のグリコサミノコンドロイチンサプリメント市場の成長の可能性を明らかにします。グリコサミノコンドロイチンサプリメントは今後の市場でも安定した成長が期待される。しかし、グリコサミノコンドロイチンサプリメントの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、グリコサミノコンドロイチン・サプリメント市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要がある。
世界的な高齢化が、グリコサミノグリカン・サプリメントを含む関節健康サプリメントの需要を促進している。高齢化が進むと、変形性関節症など関節に関連する問題が発生しやすくなる。関節の健康と予防医療の重要性に対する認識が高まり、グルコサミンやコンドロイチンのようなサプリメントを求める消費者が増えている。電子商取引の台頭により、消費者はGAGサプリメントを含む様々な栄養補助食品に容易にアクセスできるようになり、市場の成長に寄与している。
主な特徴
グリコサミノコンドロイチンサプリメント市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、グリコサミノコンドロイチンサプリメント市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(カプセル、タブレットなど)、地域別内訳を含む場合があります。
市場の促進要因と課題:政府規制、環境問題、技術進歩、消費者の嗜好の変化など、グリコサミノコンドロイチンサプリメント市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。
競合情勢:この調査レポートは、グリコサミノコンドロイチンサプリメント市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響も強調することができます。
技術開発:調査レポートは、グリコサミノコンドロイチンサプリメント業界における最新の技術開発を掘り下げることができます。これには、グリコサミノコンドロイチンサプリメント技術の進歩、グリコサミノコンドロイチンサプリメントの新規参入企業、グリコサミノコンドロイチンサプリメントの新規投資、グリコサミノコンドロイチンサプリメントの将来を形作るその他の技術革新が含まれます。
川下企業の好み:このレポートは、グリコサミノコンドロイチンサプリメント市場における顧客の購買行動と採用傾向に光を当てることができます。顧客の購買決定、グリコサミノコンドロイチンサプリメント製品の嗜好に影響を与える要因も含まれる。
政府の政策とインセンティブ:調査レポートは、政府の政策とインセンティブがグリコサミノコンドロイチンサプリメント市場に与える影響を分析します。これには、グリコサミノコンドロイチンサプリメント市場の促進を目的とした規制枠組み、補助金、税制優遇措置、その他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価する。
環境への影響と持続可能性調査レポートは、グリコサミノコンドロイチンサプリメント市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:実施した分析に基づき、調査レポートはグリコサミノコンドロイチンサプリメント産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、グリコサミノコンドロイチンサプリメント市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
グリコサミノコンドロイチンサプリメント市場は、タイプ別と用途別に分けられます。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
カプセル
錠剤
その他
用途別セグメント
薬局
スーパーマーケット
その他
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
サントリー
オリヒログループ
アンシン
ワントゥミン・バイオロジカル
TSIグループ
煙台東城
フォーカスケム
YBCC
倫新生物技術
ISBA
匯文
QJBCHINA
メイテック(シヌトラ・インターナショナル)
恒傑生物製薬
日本臓器
GGI
サミットニュートリショナルズ
スーファーマ
瑞康大生化学
広隆生物化学
パシフィックレインボー
サミット ニュートリショナルズ インターナショナル
ウェバーナチュラルズ
マニングス
ライフエクステンション
シフ
ドクターズベスト
オステオバイオフレックス
カークランド
本レポートで扱う主な質問
世界のグリコサミノコンドロイチンサプリメント市場の10年展望は?
グリコサミノコンドロイチンサプリメントの世界市場および地域別市場成長の要因は何か?
市場別、地域別に最も急成長する技術は何か?
グリコサミノコンドロイチンサプリメントの市場機会は最終市場規模によってどのように異なるのか?
グリコサミノコンドロイチンサプリメントのタイプ別、用途別内訳は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glycosaminochondroitin Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Glycosaminochondroitin Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Glycosaminochondroitin Supplements by Country/Region, 2018, 2022 & 2029
2.2 Glycosaminochondroitin Supplements Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.2.3 Others
2.3 Glycosaminochondroitin Supplements Sales by Type
2.3.1 Global Glycosaminochondroitin Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Glycosaminochondroitin Supplements Sale Price by Type (2018-2023)
2.4 Glycosaminochondroitin Supplements Segment by Application
2.4.1 Pharmacy
2.4.2 Supermarket
2.4.3 Others
2.5 Glycosaminochondroitin Supplements Sales by Application
2.5.1 Global Glycosaminochondroitin Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Glycosaminochondroitin Supplements Sale Price by Application (2018-2023)
3 Global Glycosaminochondroitin Supplements by Company
3.1 Global Glycosaminochondroitin Supplements Breakdown Data by Company
3.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Glycosaminochondroitin Supplements Sales Market Share by Company (2018-2023)
3.2 Global Glycosaminochondroitin Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Glycosaminochondroitin Supplements Revenue by Company (2018-2023)
3.2.2 Global Glycosaminochondroitin Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Glycosaminochondroitin Supplements Sale Price by Company
3.4 Key Manufacturers Glycosaminochondroitin Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glycosaminochondroitin Supplements Product Location Distribution
3.4.2 Players Glycosaminochondroitin Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Glycosaminochondroitin Supplements by Geographic Region
4.1 World Historic Glycosaminochondroitin Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Glycosaminochondroitin Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Glycosaminochondroitin Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Glycosaminochondroitin Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Glycosaminochondroitin Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Glycosaminochondroitin Supplements Sales Growth
4.4 APAC Glycosaminochondroitin Supplements Sales Growth
4.5 Europe Glycosaminochondroitin Supplements Sales Growth
4.6 Middle East & Africa Glycosaminochondroitin Supplements Sales Growth
5 Americas
5.1 Americas Glycosaminochondroitin Supplements Sales by Country
5.1.1 Americas Glycosaminochondroitin Supplements Sales by Country (2018-2023)
5.1.2 Americas Glycosaminochondroitin Supplements Revenue by Country (2018-2023)
5.2 Americas Glycosaminochondroitin Supplements Sales by Type
5.3 Americas Glycosaminochondroitin Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glycosaminochondroitin Supplements Sales by Region
6.1.1 APAC Glycosaminochondroitin Supplements Sales by Region (2018-2023)
6.1.2 APAC Glycosaminochondroitin Supplements Revenue by Region (2018-2023)
6.2 APAC Glycosaminochondroitin Supplements Sales by Type
6.3 APAC Glycosaminochondroitin Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glycosaminochondroitin Supplements by Country
7.1.1 Europe Glycosaminochondroitin Supplements Sales by Country (2018-2023)
7.1.2 Europe Glycosaminochondroitin Supplements Revenue by Country (2018-2023)
7.2 Europe Glycosaminochondroitin Supplements Sales by Type
7.3 Europe Glycosaminochondroitin Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glycosaminochondroitin Supplements by Country
8.1.1 Middle East & Africa Glycosaminochondroitin Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Glycosaminochondroitin Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Glycosaminochondroitin Supplements Sales by Type
8.3 Middle East & Africa Glycosaminochondroitin Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glycosaminochondroitin Supplements
10.3 Manufacturing Process Analysis of Glycosaminochondroitin Supplements
10.4 Industry Chain Structure of Glycosaminochondroitin Supplements
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glycosaminochondroitin Supplements Distributors
11.3 Glycosaminochondroitin Supplements Customer
12 World Forecast Review for Glycosaminochondroitin Supplements by Geographic Region
12.1 Global Glycosaminochondroitin Supplements Market Size Forecast by Region
12.1.1 Global Glycosaminochondroitin Supplements Forecast by Region (2024-2029)
12.1.2 Global Glycosaminochondroitin Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glycosaminochondroitin Supplements Forecast by Type
12.7 Global Glycosaminochondroitin Supplements Forecast by Application
13 Key Players Analysis
13.1 Suntory
13.1.1 Suntory Company Information
13.1.2 Suntory Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.1.3 Suntory Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Suntory Main Business Overview
13.1.5 Suntory Latest Developments
13.2 Orihiro Group
13.2.1 Orihiro Group Company Information
13.2.2 Orihiro Group Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.2.3 Orihiro Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Orihiro Group Main Business Overview
13.2.5 Orihiro Group Latest Developments
13.3 ANXIN
13.3.1 ANXIN Company Information
13.3.2 ANXIN Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.3.3 ANXIN Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ANXIN Main Business Overview
13.3.5 ANXIN Latest Developments
13.4 WanTuMing Biological
13.4.1 WanTuMing Biological Company Information
13.4.2 WanTuMing Biological Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.4.3 WanTuMing Biological Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 WanTuMing Biological Main Business Overview
13.4.5 WanTuMing Biological Latest Developments
13.5 TSI Group
13.5.1 TSI Group Company Information
13.5.2 TSI Group Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.5.3 TSI Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TSI Group Main Business Overview
13.5.5 TSI Group Latest Developments
13.6 Yantai Dongcheng
13.6.1 Yantai Dongcheng Company Information
13.6.2 Yantai Dongcheng Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.6.3 Yantai Dongcheng Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yantai Dongcheng Main Business Overview
13.6.5 Yantai Dongcheng Latest Developments
13.7 Focus Chem
13.7.1 Focus Chem Company Information
13.7.2 Focus Chem Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.7.3 Focus Chem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Focus Chem Main Business Overview
13.7.5 Focus Chem Latest Developments
13.8 YBCC
13.8.1 YBCC Company Information
13.8.2 YBCC Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.8.3 YBCC Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 YBCC Main Business Overview
13.8.5 YBCC Latest Developments
13.9 Runxin Biotechnology
13.9.1 Runxin Biotechnology Company Information
13.9.2 Runxin Biotechnology Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.9.3 Runxin Biotechnology Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Runxin Biotechnology Main Business Overview
13.9.5 Runxin Biotechnology Latest Developments
13.10 ISBA
13.10.1 ISBA Company Information
13.10.2 ISBA Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.10.3 ISBA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ISBA Main Business Overview
13.10.5 ISBA Latest Developments
13.11 Huiwen
13.11.1 Huiwen Company Information
13.11.2 Huiwen Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.11.3 Huiwen Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Huiwen Main Business Overview
13.11.5 Huiwen Latest Developments
13.12 QJBCHINA
13.12.1 QJBCHINA Company Information
13.12.2 QJBCHINA Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.12.3 QJBCHINA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 QJBCHINA Main Business Overview
13.12.5 QJBCHINA Latest Developments
13.13 Meitek(Synutra International)
13.13.1 Meitek(Synutra International) Company Information
13.13.2 Meitek(Synutra International) Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.13.3 Meitek(Synutra International) Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Meitek(Synutra International) Main Business Overview
13.13.5 Meitek(Synutra International) Latest Developments
13.14 Hengjie Bio-Pharmaceuticals
13.14.1 Hengjie Bio-Pharmaceuticals Company Information
13.14.2 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.14.3 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hengjie Bio-Pharmaceuticals Main Business Overview
13.14.5 Hengjie Bio-Pharmaceuticals Latest Developments
13.15 Nippon Zoki
13.15.1 Nippon Zoki Company Information
13.15.2 Nippon Zoki Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.15.3 Nippon Zoki Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Nippon Zoki Main Business Overview
13.15.5 Nippon Zoki Latest Developments
13.16 GGI
13.16.1 GGI Company Information
13.16.2 GGI Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.16.3 GGI Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 GGI Main Business Overview
13.16.5 GGI Latest Developments
13.17 Summit Nutritionals
13.17.1 Summit Nutritionals Company Information
13.17.2 Summit Nutritionals Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.17.3 Summit Nutritionals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Summit Nutritionals Main Business Overview
13.17.5 Summit Nutritionals Latest Developments
13.18 Sioux Pharm
13.18.1 Sioux Pharm Company Information
13.18.2 Sioux Pharm Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.18.3 Sioux Pharm Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Sioux Pharm Main Business Overview
13.18.5 Sioux Pharm Latest Developments
13.19 Ruikangda Biochemical
13.19.1 Ruikangda Biochemical Company Information
13.19.2 Ruikangda Biochemical Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.19.3 Ruikangda Biochemical Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ruikangda Biochemical Main Business Overview
13.19.5 Ruikangda Biochemical Latest Developments
13.20 Guanglong Biochem
13.20.1 Guanglong Biochem Company Information
13.20.2 Guanglong Biochem Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.20.3 Guanglong Biochem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Guanglong Biochem Main Business Overview
13.20.5 Guanglong Biochem Latest Developments
13.21 Pacific Rainbow
13.21.1 Pacific Rainbow Company Information
13.21.2 Pacific Rainbow Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.21.3 Pacific Rainbow Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Pacific Rainbow Main Business Overview
13.21.5 Pacific Rainbow Latest Developments
13.22 Summit Nutritionals International
13.22.1 Summit Nutritionals International Company Information
13.22.2 Summit Nutritionals International Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.22.3 Summit Nutritionals International Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Summit Nutritionals International Main Business Overview
13.22.5 Summit Nutritionals International Latest Developments
13.23 Webber Naturals
13.23.1 Webber Naturals Company Information
13.23.2 Webber Naturals Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.23.3 Webber Naturals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Webber Naturals Main Business Overview
13.23.5 Webber Naturals Latest Developments
13.24 Mannings
13.24.1 Mannings Company Information
13.24.2 Mannings Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.24.3 Mannings Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Mannings Main Business Overview
13.24.5 Mannings Latest Developments
13.25 Life Extension
13.25.1 Life Extension Company Information
13.25.2 Life Extension Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.25.3 Life Extension Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Life Extension Main Business Overview
13.25.5 Life Extension Latest Developments
13.26 Schiff
13.26.1 Schiff Company Information
13.26.2 Schiff Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.26.3 Schiff Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 Schiff Main Business Overview
13.26.5 Schiff Latest Developments
13.27 Doctor's Best
13.27.1 Doctor's Best Company Information
13.27.2 Doctor's Best Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.27.3 Doctor's Best Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.27.4 Doctor's Best Main Business Overview
13.27.5 Doctor's Best Latest Developments
13.28 Osteo Bi-Flex
13.28.1 Osteo Bi-Flex Company Information
13.28.2 Osteo Bi-Flex Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.28.3 Osteo Bi-Flex Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.28.4 Osteo Bi-Flex Main Business Overview
13.28.5 Osteo Bi-Flex Latest Developments
13.29 Kirkland
13.29.1 Kirkland Company Information
13.29.2 Kirkland Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.29.3 Kirkland Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.29.4 Kirkland Main Business Overview
13.29.5 Kirkland Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Glycosaminochondroitin Supplements market size was valued at US$ million in 2022. With growing demand in downstream market, the Glycosaminochondroitin Supplements is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Glycosaminochondroitin Supplements market. Glycosaminochondroitin Supplements are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glycosaminochondroitin Supplements. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glycosaminochondroitin Supplements market.
The aging population worldwide is driving the demand for joint health supplements, including glycosaminoglycan supplements. As people age, they are more likely to experience joint-related issues, such as osteoarthritis. There is a growing awareness of the importance of joint health and preventive healthcare, leading more consumers to seek out supplements like glucosamine and chondroitin. The rise of e-commerce has made it easier for consumers to access a wide range of dietary supplements, including GAG supplements, contributing to market growth.
Key Features:
The report on Glycosaminochondroitin Supplements market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glycosaminochondroitin Supplements market. It may include historical data, market segmentation by Type (e.g., Capsule, Tablet), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glycosaminochondroitin Supplements market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glycosaminochondroitin Supplements market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glycosaminochondroitin Supplements industry. This include advancements in Glycosaminochondroitin Supplements technology, Glycosaminochondroitin Supplements new entrants, Glycosaminochondroitin Supplements new investment, and other innovations that are shaping the future of Glycosaminochondroitin Supplements.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glycosaminochondroitin Supplements market. It includes factors influencing customer ' purchasing decisions, preferences for Glycosaminochondroitin Supplements product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glycosaminochondroitin Supplements market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glycosaminochondroitin Supplements market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glycosaminochondroitin Supplements market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glycosaminochondroitin Supplements industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glycosaminochondroitin Supplements market.
Market Segmentation:
Glycosaminochondroitin Supplements market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Capsule
Tablet
Others
Segmentation by application
Pharmacy
Supermarket
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Suntory
Orihiro Group
ANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek(Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow
Summit Nutritionals International
Webber Naturals
Mannings
Life Extension
Schiff
Doctor's Best
Osteo Bi-Flex
Kirkland
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glycosaminochondroitin Supplements market?
What factors are driving Glycosaminochondroitin Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glycosaminochondroitin Supplements market opportunities vary by end market size?
How does Glycosaminochondroitin Supplements break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glycosaminochondroitin Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Glycosaminochondroitin Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Glycosaminochondroitin Supplements by Country/Region, 2018, 2022 & 2029
2.2 Glycosaminochondroitin Supplements Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.2.3 Others
2.3 Glycosaminochondroitin Supplements Sales by Type
2.3.1 Global Glycosaminochondroitin Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Glycosaminochondroitin Supplements Sale Price by Type (2018-2023)
2.4 Glycosaminochondroitin Supplements Segment by Application
2.4.1 Pharmacy
2.4.2 Supermarket
2.4.3 Others
2.5 Glycosaminochondroitin Supplements Sales by Application
2.5.1 Global Glycosaminochondroitin Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Glycosaminochondroitin Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Glycosaminochondroitin Supplements Sale Price by Application (2018-2023)
3 Global Glycosaminochondroitin Supplements by Company
3.1 Global Glycosaminochondroitin Supplements Breakdown Data by Company
3.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Glycosaminochondroitin Supplements Sales Market Share by Company (2018-2023)
3.2 Global Glycosaminochondroitin Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Glycosaminochondroitin Supplements Revenue by Company (2018-2023)
3.2.2 Global Glycosaminochondroitin Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Glycosaminochondroitin Supplements Sale Price by Company
3.4 Key Manufacturers Glycosaminochondroitin Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glycosaminochondroitin Supplements Product Location Distribution
3.4.2 Players Glycosaminochondroitin Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Glycosaminochondroitin Supplements by Geographic Region
4.1 World Historic Glycosaminochondroitin Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Glycosaminochondroitin Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Glycosaminochondroitin Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Glycosaminochondroitin Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Glycosaminochondroitin Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Glycosaminochondroitin Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Glycosaminochondroitin Supplements Sales Growth
4.4 APAC Glycosaminochondroitin Supplements Sales Growth
4.5 Europe Glycosaminochondroitin Supplements Sales Growth
4.6 Middle East & Africa Glycosaminochondroitin Supplements Sales Growth
5 Americas
5.1 Americas Glycosaminochondroitin Supplements Sales by Country
5.1.1 Americas Glycosaminochondroitin Supplements Sales by Country (2018-2023)
5.1.2 Americas Glycosaminochondroitin Supplements Revenue by Country (2018-2023)
5.2 Americas Glycosaminochondroitin Supplements Sales by Type
5.3 Americas Glycosaminochondroitin Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glycosaminochondroitin Supplements Sales by Region
6.1.1 APAC Glycosaminochondroitin Supplements Sales by Region (2018-2023)
6.1.2 APAC Glycosaminochondroitin Supplements Revenue by Region (2018-2023)
6.2 APAC Glycosaminochondroitin Supplements Sales by Type
6.3 APAC Glycosaminochondroitin Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glycosaminochondroitin Supplements by Country
7.1.1 Europe Glycosaminochondroitin Supplements Sales by Country (2018-2023)
7.1.2 Europe Glycosaminochondroitin Supplements Revenue by Country (2018-2023)
7.2 Europe Glycosaminochondroitin Supplements Sales by Type
7.3 Europe Glycosaminochondroitin Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glycosaminochondroitin Supplements by Country
8.1.1 Middle East & Africa Glycosaminochondroitin Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Glycosaminochondroitin Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Glycosaminochondroitin Supplements Sales by Type
8.3 Middle East & Africa Glycosaminochondroitin Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glycosaminochondroitin Supplements
10.3 Manufacturing Process Analysis of Glycosaminochondroitin Supplements
10.4 Industry Chain Structure of Glycosaminochondroitin Supplements
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glycosaminochondroitin Supplements Distributors
11.3 Glycosaminochondroitin Supplements Customer
12 World Forecast Review for Glycosaminochondroitin Supplements by Geographic Region
12.1 Global Glycosaminochondroitin Supplements Market Size Forecast by Region
12.1.1 Global Glycosaminochondroitin Supplements Forecast by Region (2024-2029)
12.1.2 Global Glycosaminochondroitin Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glycosaminochondroitin Supplements Forecast by Type
12.7 Global Glycosaminochondroitin Supplements Forecast by Application
13 Key Players Analysis
13.1 Suntory
13.1.1 Suntory Company Information
13.1.2 Suntory Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.1.3 Suntory Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Suntory Main Business Overview
13.1.5 Suntory Latest Developments
13.2 Orihiro Group
13.2.1 Orihiro Group Company Information
13.2.2 Orihiro Group Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.2.3 Orihiro Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Orihiro Group Main Business Overview
13.2.5 Orihiro Group Latest Developments
13.3 ANXIN
13.3.1 ANXIN Company Information
13.3.2 ANXIN Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.3.3 ANXIN Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ANXIN Main Business Overview
13.3.5 ANXIN Latest Developments
13.4 WanTuMing Biological
13.4.1 WanTuMing Biological Company Information
13.4.2 WanTuMing Biological Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.4.3 WanTuMing Biological Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 WanTuMing Biological Main Business Overview
13.4.5 WanTuMing Biological Latest Developments
13.5 TSI Group
13.5.1 TSI Group Company Information
13.5.2 TSI Group Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.5.3 TSI Group Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TSI Group Main Business Overview
13.5.5 TSI Group Latest Developments
13.6 Yantai Dongcheng
13.6.1 Yantai Dongcheng Company Information
13.6.2 Yantai Dongcheng Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.6.3 Yantai Dongcheng Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yantai Dongcheng Main Business Overview
13.6.5 Yantai Dongcheng Latest Developments
13.7 Focus Chem
13.7.1 Focus Chem Company Information
13.7.2 Focus Chem Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.7.3 Focus Chem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Focus Chem Main Business Overview
13.7.5 Focus Chem Latest Developments
13.8 YBCC
13.8.1 YBCC Company Information
13.8.2 YBCC Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.8.3 YBCC Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 YBCC Main Business Overview
13.8.5 YBCC Latest Developments
13.9 Runxin Biotechnology
13.9.1 Runxin Biotechnology Company Information
13.9.2 Runxin Biotechnology Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.9.3 Runxin Biotechnology Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Runxin Biotechnology Main Business Overview
13.9.5 Runxin Biotechnology Latest Developments
13.10 ISBA
13.10.1 ISBA Company Information
13.10.2 ISBA Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.10.3 ISBA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ISBA Main Business Overview
13.10.5 ISBA Latest Developments
13.11 Huiwen
13.11.1 Huiwen Company Information
13.11.2 Huiwen Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.11.3 Huiwen Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Huiwen Main Business Overview
13.11.5 Huiwen Latest Developments
13.12 QJBCHINA
13.12.1 QJBCHINA Company Information
13.12.2 QJBCHINA Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.12.3 QJBCHINA Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 QJBCHINA Main Business Overview
13.12.5 QJBCHINA Latest Developments
13.13 Meitek(Synutra International)
13.13.1 Meitek(Synutra International) Company Information
13.13.2 Meitek(Synutra International) Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.13.3 Meitek(Synutra International) Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Meitek(Synutra International) Main Business Overview
13.13.5 Meitek(Synutra International) Latest Developments
13.14 Hengjie Bio-Pharmaceuticals
13.14.1 Hengjie Bio-Pharmaceuticals Company Information
13.14.2 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.14.3 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hengjie Bio-Pharmaceuticals Main Business Overview
13.14.5 Hengjie Bio-Pharmaceuticals Latest Developments
13.15 Nippon Zoki
13.15.1 Nippon Zoki Company Information
13.15.2 Nippon Zoki Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.15.3 Nippon Zoki Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Nippon Zoki Main Business Overview
13.15.5 Nippon Zoki Latest Developments
13.16 GGI
13.16.1 GGI Company Information
13.16.2 GGI Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.16.3 GGI Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 GGI Main Business Overview
13.16.5 GGI Latest Developments
13.17 Summit Nutritionals
13.17.1 Summit Nutritionals Company Information
13.17.2 Summit Nutritionals Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.17.3 Summit Nutritionals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Summit Nutritionals Main Business Overview
13.17.5 Summit Nutritionals Latest Developments
13.18 Sioux Pharm
13.18.1 Sioux Pharm Company Information
13.18.2 Sioux Pharm Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.18.3 Sioux Pharm Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Sioux Pharm Main Business Overview
13.18.5 Sioux Pharm Latest Developments
13.19 Ruikangda Biochemical
13.19.1 Ruikangda Biochemical Company Information
13.19.2 Ruikangda Biochemical Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.19.3 Ruikangda Biochemical Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ruikangda Biochemical Main Business Overview
13.19.5 Ruikangda Biochemical Latest Developments
13.20 Guanglong Biochem
13.20.1 Guanglong Biochem Company Information
13.20.2 Guanglong Biochem Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.20.3 Guanglong Biochem Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Guanglong Biochem Main Business Overview
13.20.5 Guanglong Biochem Latest Developments
13.21 Pacific Rainbow
13.21.1 Pacific Rainbow Company Information
13.21.2 Pacific Rainbow Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.21.3 Pacific Rainbow Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Pacific Rainbow Main Business Overview
13.21.5 Pacific Rainbow Latest Developments
13.22 Summit Nutritionals International
13.22.1 Summit Nutritionals International Company Information
13.22.2 Summit Nutritionals International Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.22.3 Summit Nutritionals International Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Summit Nutritionals International Main Business Overview
13.22.5 Summit Nutritionals International Latest Developments
13.23 Webber Naturals
13.23.1 Webber Naturals Company Information
13.23.2 Webber Naturals Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.23.3 Webber Naturals Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Webber Naturals Main Business Overview
13.23.5 Webber Naturals Latest Developments
13.24 Mannings
13.24.1 Mannings Company Information
13.24.2 Mannings Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.24.3 Mannings Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Mannings Main Business Overview
13.24.5 Mannings Latest Developments
13.25 Life Extension
13.25.1 Life Extension Company Information
13.25.2 Life Extension Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.25.3 Life Extension Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Life Extension Main Business Overview
13.25.5 Life Extension Latest Developments
13.26 Schiff
13.26.1 Schiff Company Information
13.26.2 Schiff Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.26.3 Schiff Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 Schiff Main Business Overview
13.26.5 Schiff Latest Developments
13.27 Doctor's Best
13.27.1 Doctor's Best Company Information
13.27.2 Doctor's Best Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.27.3 Doctor's Best Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.27.4 Doctor's Best Main Business Overview
13.27.5 Doctor's Best Latest Developments
13.28 Osteo Bi-Flex
13.28.1 Osteo Bi-Flex Company Information
13.28.2 Osteo Bi-Flex Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.28.3 Osteo Bi-Flex Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.28.4 Osteo Bi-Flex Main Business Overview
13.28.5 Osteo Bi-Flex Latest Developments
13.29 Kirkland
13.29.1 Kirkland Company Information
13.29.2 Kirkland Glycosaminochondroitin Supplements Product Portfolios and Specifications
13.29.3 Kirkland Glycosaminochondroitin Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.29.4 Kirkland Main Business Overview
13.29.5 Kirkland Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/06/21 10:26

160.10 円

171.83 円

205.37 円

ページTOPに戻る